Clinical Trials Browser

pasireotide × Breast × Clear all

NCT01356862 2017-01-25

SOM 230

Phase 2 Completed

Breast Neoplasms

NCT01372644 2016-12-05

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Phase 1 Completed

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating